Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer

  Free Subscription

Articles published in Urology

Retrieve available abstracts of 130 articles:
HTML format

Single Articles

    August 2021
  1. SUER E, Karaburun MC, Babayigit M, Akpinar C, et al
    Does switching Bacillus Calmette-Guerin strains during maintenance therapy affect the outcome in non-muscle invasive bladder cancer?
    Urology. 2021 Aug 21. pii: S0090-4295(21)00781.
    PubMed     Abstract available

    July 2021
  2. RICHTER LA, Egan J, Alagha EC, Handa VL, et al
    Vaginal Complications after Radical Cystectomy for Bladder Cancer: A Systematic Review.
    Urology. 2021 Jul 17. pii: S0090-4295(21)00656.
    PubMed     Abstract available

  3. HERR H, Vertosick EA, Dalbagni G, Cha EK, et al
    Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urology. 2021 Jul 15. pii: S0090-4295(21)00642.
    PubMed     Abstract available

  4. KUPERUS JM, Busman RD, Kuipers SK, Broekhuizen HT, et al
    Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG, and Gemcitabine for Non-Muscle Invasive Bladder Cancer.
    Urology. 2021 Jul 1. pii: S0090-4295(21)00577.
    PubMed     Abstract available

    June 2021
  5. CHAPPIDI MR, Welty C, Choi W, Meng MV, et al
    Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort.
    Urology. 2021 Jun 9. pii: S0090-4295(21)00473.
    PubMed     Abstract available

    May 2021
  6. NABAVIZADEH B, Amend GM, Breyer BN
    Workers Died of Dyes: The Discovery of Occupational Bladder Cancers.
    Urology. 2021 May 16. pii: S0090-4295(21)00400.

    April 2021
  7. SHA ST, Dee EC, Mossanen M, Mahal BA, et al
    Clinical characterization of radiation-associated muscle-invasive bladder cancer.
    Urology. 2021 Apr 12. pii: S0090-4295(21)00318.
    PubMed     Abstract available

    March 2021
  8. NARAIN TA, Tosh JM, Gautam G, Talwar HS, et al
    Neoadjuvant therapy for cisplatin ineligible muscle invasive bladder cancer patients: A review of available evidence.
    Urology. 2021 Mar 24. pii: S0090-4295(21)00267.
    PubMed     Abstract available

    January 2021
  9. BASSETT JC, Matulewicz RS, Kwan L, McCarthy WJ, et al
    Prevalence and Correlates of Successful Smoking Cessation in Bladder Cancer Survivors.
    Urology. 2021 Jan 12. pii: S0090-4295(21)00047.
    PubMed     Abstract available

    December 2020
  10. NYAME YA, Holt SK, Diamontopolous L, Winters BR, et al
    Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries with Muscle Invasive Bladder Cancer from 2004-2015.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31518.
    PubMed     Abstract available

    November 2020
  11. KOCH GE, Smelser WW, Chang SS
    Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How To Manage Them.
    Urology. 2020 Nov 9. pii: S0090-4295(20)31349.
    PubMed     Abstract available

    October 2020
  12. MAGGEN C, Linssen J, Gziri MM, Zola P, et al
    Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management.
    Urology. 2020 Oct 22. pii: S0090-4295(20)31271.
    PubMed     Abstract available

    September 2020
  13. BAGHERI I, Shan Y, Klaassen Z, Kamat AM, et al
    Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.
    Urology. 2020 Sep 24. pii: S0090-4295(20)31169.
    PubMed     Abstract available

    August 2020
  14. DARWISH C, Sparks A, Amdur R, Reddy A, et al
    Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database.
    Urology. 2020 Aug 28. pii: S0090-4295(20)31013.
    PubMed     Abstract available

  15. GUPTA N, Rasmussen SEVP, Haney N, Smith A, et al
    Understanding psychosocial and sexual health concerns among women with bladder cancer undergoing radical cystectomy.
    Urology. 2020 Aug 24. pii: S0090-4295(20)31008.
    PubMed     Abstract available

  16. MARINARO J, Zeymo A, Egan J, Carvalho F, et al
    Sex and Racial Disparities in the Treatment and Outcomes of Muscle-Invasive Bladder Cancer.
    Urology. 2020 Aug 15. pii: S0090-4295(20)30992.
    PubMed     Abstract available

  17. TULLY KH, Cole AP, Krimphove MJ, Friedlander DF, et al
    Contemporary treatment patterns for Non-Muscle Invasive Bladder Cancer: Has the Use of Radical Cystectomy changed in the BCG Shortage Era?
    Urology. 2020 Aug 14. pii: S0090-4295(20)30983.
    PubMed     Abstract available

    July 2020
  18. KAYE DR, Schafer C, Thelen-Perry S, Parker C, et al
    The feasibility and impact of a pre-surgical exercise intervention program (prehabilitation) for patients undergoing cystectomy for bladder cancer.
    Urology. 2020 Jul 30. pii: S0090-4295(20)30933.
    PubMed     Abstract available

  19. CORNELISSEN SWE, Veenboer PW, Wessels FJ, Meijer RP, et al
    Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: A systematic review and meta-analysis.
    Urology. 2020 Jul 25. pii: S0090-4295(20)30882.
    PubMed     Abstract available

  20. RICHARDS KA, Lin SW, Chuo CY, Derleth CL, et al
    Increased Bacillus Calmette-Guerin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non-Muscle-Invasive Bladder Cancer in US Clinical Practice.
    Urology. 2020 Jul 24. pii: S0090-4295(20)30884.
    PubMed     Abstract available

  21. BUKAVINA L, Prunty M, Mishra K, Sun H, et al
    Gender Disparities in Bladder Cancer Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS).
    Urology. 2020 Jul 21. pii: S0090-4295(20)30868.
    PubMed     Abstract available

  22. GRAJALES V, Bandari J, Hale NE, Yabes JG, et al
    Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer.
    Urology. 2020 Jul 13. pii: S0090-4295(20)30823.
    PubMed     Abstract available

  23. YAN H, Dittmar F, Schagdarsurengin U, Wagenlehner F, et al
    The clinical application and potential roles of circulating tumor cells in bladder cancer and prostate cancer.
    Urology. 2020 Jul 4. pii: S0090-4295(20)30799.
    PubMed     Abstract available

    May 2020
  24. KOCH GE, Luckenbaugh AN, Chang SS
    High-Risk Non-Muscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.
    Urology. 2020 May 20. pii: S0090-4295(20)30573.
    PubMed     Abstract available

    April 2020
  25. PEARD L, Stark T, Ziada A, Saltzman AF, et al
    Recurrent Bladder Cancer in a Teenage Male.
    Urology. 2020 Apr 22. pii: S0090-4295(20)30411.
    PubMed     Abstract available

    March 2020
  26. AGARD H, Clark C, Massanyi E, Steele M, et al
    Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
    Urology. 2020;137:173-177.
    PubMed     Abstract available

  27. DREJER D, Moltke AL, Nielsen AM, Lam GW, et al
    DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study With Focus on Recurrence.
    Urology. 2020;137:91-96.
    PubMed     Abstract available

  28. HALSTEAD NV, Cost NG, Hecht SL, Walker JP, et al
    Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence.
    Urology. 2020;137:168-172.
    PubMed     Abstract available

  29. HECHT SL, Walker JP, Treece AL, Cost NG, et al
    Isolated Pure Malignant Rhabdoid Tumor (MRT) of the Bladder: Case Report and Lessons Learned.
    Urology. 2020;137:164-167.
    PubMed     Abstract available

  30. YONG C, Steinberg RL, O'Donnell MA
    Severe Infectious Complications of Intravesical Bacillus Calmette-Guerin: A Case Series of 10 Patients.
    Urology. 2020;137:79-83.
    PubMed     Abstract available

    February 2020
  31. NASSIRI N, Maas M, Asanad K, Daneshmand S, et al
    Detecting Invisible Bladder Cancers with Blue Light Cystoscopy.
    Urology. 2020 Feb 19. pii: S0090-4295(20)30182.
    PubMed     Abstract available

  32. DAS H, Rodriguez R
    Health Care Disparities in Urologic Oncology: A Systematic Review.
    Urology. 2020;136:9-18.
    PubMed     Abstract available

    January 2020
  33. MYRGA JM, Ayyash OM, Bandari J, Fam MM, et al
    The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy.
    Urology. 2020;135:106-110.
    PubMed     Abstract available

  34. GOH AC, Belarmino A, Patel NA, Sun T, et al
    A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy.
    Urology. 2020;135:57-65.
    PubMed     Abstract available

  35. TULLY KH, Krimphove MJ, Reese SW, Kibel AS, et al
    Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy.
    Urology. 2020;135:44-49.
    PubMed     Abstract available

    December 2019
  36. RIOS EM, Parma MA, Fernandez RA, Clinton TN, et al
    Urinary diversion disparity following radical cystectomy for bladder cancer in the Hispanic population.
    Urology. 2019 Dec 26. pii: S0090-4295(19)31119.
    PubMed     Abstract available

  37. ANDERSON AG, Murray KS
    Urology. 2019;134:160-161.

  38. OTTA-OSHIRO RJ, Lista-Mateos F, Encinas-Garcia S, Morales-Garcia S, et al
    Metachronous Signet Ring Cell Bladder Metastasis as First Sing of Cancer Recurrence.
    Urology. 2019;134:e1-e2.
    PubMed     Abstract available

  39. LIN FC, Medendorp A, Van Kuiken M, Mills SA, et al
    Vaginal Dehiscence and Evisceration After Robotic-assisted Radical Cystectomy: A Case Series and Review of the Literature.
    Urology. 2019;134:90-96.
    PubMed     Abstract available

    November 2019
  40. SOLANKI AA, Efstathiou JA
    Urology. 2019;133:171-172.

  41. LEE BH
    Urology. 2019;133:161-162.

  42. MICHEL J, Goel AN, Golla V, Lenis AT, et al
    Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty.
    Urology. 2019;133:25-33.
    PubMed     Abstract available

    September 2019
  43. AJAJ R, Berlin A, Klaassen Z, Chandrasekar T, et al
    Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients - A Cross Sectional Study.
    Urology. 2019 Sep 2. pii: S0090-4295(19)30786.
    PubMed     Abstract available

  44. GURUNG PMS, Messing EE, Joseph JV
    Urology. 2019;131:118-119.

    Urology. 2019;131:102.

  46. LEINWAND GZ, Greenberg JW, Sholl AB, Krane LS, et al
    Synchronous Urothelial Bladder and Renal Malignancies. Case Report and Review of Urologic Cancers in Patients With Familial Rb Mutations.
    Urology. 2019;131:89-92.
    PubMed     Abstract available

    August 2019
  47. LIN-BRANDE M, Pearce SM, Ashrafi AN, Nazemi A, et al
    Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
    Urology. 2019 Aug 14. pii: S0090-4295(19)30721.
    PubMed     Abstract available

  48. KAUSHIK D, Wang H, Michalek J, Liss MA, et al
    Chemoradiation Versus Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Propensity Score-Weighted Comparative Analysis Using the National Cancer Database.
    Urology. 2019 Aug 8. pii: S0090-4295(19)30701.
    PubMed     Abstract available

  49. BADIN J, Abello A, Gupta M, Das AK, et al
    Urology. 2019 Aug 7. pii: S0090-4295(19)30700.

  50. PENTICUFF J, McDermott S, Carrasco A, Bowlin P, et al
    Second Reported Case of Pediatric Bladder Alveolar Soft Part Sarcoma as Secondary Malignancy After Prior Cytotoxic Chemotherapy.
    Urology. 2019;130:148-150.
    PubMed     Abstract available

    July 2019
  51. HAYWOOD SC, Long Roche K, Bochner BH
    A Thoughtful Pause for Sparing Oophorectomy.
    Urology. 2019;129:237.

  52. BERTOLO R, Agudelo J, Garisto J, Armanyous S, et al
    Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study.
    Urology. 2019;129:98-105.
    PubMed     Abstract available

    June 2019
  53. TOBERT CM, Nepple KG, McDowell BD, Charlton ME, et al
    Urology. 2019 Jun 25. pii: S0090-4295(19)30562.
    PubMed     Abstract available

  54. PATEL KR, Taylor BL, Khani F, Guzzo TJ, et al
    Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer.
    Urology. 2019 Jun 12. pii: S0090-4295(19)30528.
    PubMed     Abstract available

  55. CORBETT CJ, Xia L, Mamtani R, Malkowicz SB, et al
    Survival Benefit Persists with Delayed Initiation of Adjuvant Chemotherapy following Radical Cystectomy for Locally Advanced Bladder Cancer.
    Urology. 2019 Jun 11. pii: S0090-4295(19)30522.
    PubMed     Abstract available

  56. HERR H
    Urology. 2019;128:60.

  57. MUKHERJEE P, George AJP, Yadav BK, Jeyaseelan L, et al
    The Impact of Narrow Band Imaging in the Detection and Resection of Bladder Tumor in Transitional Cell Carcinoma of the Bladder: A Prospective, Blinded, Sequential Intervention Randomized Controlled Trial.
    Urology. 2019;128:55-61.
    PubMed     Abstract available

    May 2019
  58. HAN DS, Lynch KE, Chang JW, Sirovich B, et al
    Overuse of Cystoscopic Surveillance among Patients with Low-Risk Non-Muscle-Invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors.
    Urology. 2019 May 27. pii: S0090-4295(19)30448.
    PubMed     Abstract available

  59. DANFORTH KN, Sidell MA, Luong TQ, Yi DK, et al
    Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Non-Muscle Invasive Bladder Cancer within a Large, Diverse Integrated Delivery System.
    Urology. 2019 May 24. pii: S0090-4295(19)30442.
    PubMed     Abstract available

  60. HERR H
    Preventable Cancer Deaths associated with Bladder-Preservation for Muscle Invasive Bladder Cancer.
    Urology. 2019 May 6. pii: S0090-4295(19)30425.

  61. BAT T, Buck DA, Nathan R, Cinquino J, et al
    Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report.
    Urology. 2019 May 3. pii: S0090-4295(19)30421.

    April 2019
  62. MAGANTY A, Turner RM 2nd, Yabes JG, Davies BJ, et al
    Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer.
    Urology. 2019 Apr 18. pii: S0090-4295(19)30353.
    PubMed     Abstract available

  63. LORENZO SORIANO L, Ordaz Jurado G, Pontones Moreno JL, Villarroya Castillo S, et al
    Urology. 2019 Apr 12. pii: S0090-4295(19)30344.
    PubMed     Abstract available

    March 2019
  64. MAY D, Canter DJ
    Urology. 2019;125:228-229.

    Urology. 2019;125:152-153.

  66. PEREIRA JF, Pareek G, Mueller-Leonhard C, Zhang Z, et al
    The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement.
    Urology. 2019;125:131-137.
    PubMed     Abstract available

  67. MODI PK, Hollenbeck BK, Oerline M, Weizer AZ, et al
    Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.
    Urology. 2019;125:86-91.
    PubMed     Abstract available

    February 2019
  68. ROYCE TJ, Efstathiou JA
    Editorial comment.
    Urology. 2019;124:189-190.

  69. BANDARI J, Maganty A, Davies BJ
    Editorial Comment.
    Urology. 2019;124:125-126.

  70. HONG P, Ding GP, Hao H, Yang KL, et al
    Laparoscopic Radical Cystectomy With Extracorporeal Neobladder: Our Initial Experience.
    Urology. 2019;124:286-291.
    PubMed     Abstract available

  71. RAGUE JT, Lee RS
    Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.
    Urology. 2019;124:257-259.
    PubMed     Abstract available

  72. HERR H, Donat M
    Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.
    Urology. 2019;124:179-182.
    PubMed     Abstract available

    January 2019
  73. GONZALEZ AN, Lipsky MJ, Li G, Rutman MP, et al
    The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria.
    Urology. 2019 Jan 21. pii: S0090-4295(19)30073.
    PubMed     Abstract available

  74. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    PubMed     Abstract available

  75. BAJIC P, Wolfe AJ, Gupta GN
    The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Urology. 2019 Jan 4. pii: S0090-4295(19)30006.
    PubMed     Abstract available

  76. HOARE D, Kiddoo D, Stryker T
    An Antenatally Detected Pure Malignant Rhabdoid Tumor of the Bladder.
    Urology. 2019;123:221-223.
    PubMed     Abstract available

  77. SYU SH, Chan KS, Hsiao CH, Chen WY, et al
    A Large Urinary Bladder Hemangioma Mimicking Urachal Cancer: A Case Report and Literature Review.
    Urology. 2019;123:224-226.
    PubMed     Abstract available

  78. KAYE DR, Ye Z, Li J, Herrel LA, et al
    The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
    Urology. 2019;123:114-119.
    PubMed     Abstract available

    December 2018
  79. BRISBANE WG, Holt SK, Winters BR, Gore JL, et al
    Non-Muscle Invasive Bladder Cancer Influences Physical Health Related Quality of Life and Urinary Incontinence.
    Urology. 2018 Dec 12. pii: S0090-4295(18)31312.
    PubMed     Abstract available

    November 2018
  80. KWAN ML, Leo MC, Danforth KN, Weinmann S, et al
    Factors that Influence Selection of Urinary Diversion among Bladder Cancer Patients in Three Community-Based Integrated Health Care Systems.
    Urology. 2018 Nov 21. pii: S0090-4295(18)31217.
    PubMed     Abstract available

  81. BAI S, Yao Z, Zhu X, Li Z, et al
    The feasibility and safety of reproductive organ preserving radical cystectomy for elderly female patients with muscle invasive bladder cancer: a retrospective propensity score-matched study.
    Urology. 2018 Nov 13. pii: S0090-4295(18)31139.
    PubMed     Abstract available

  82. HUGAR LA, Yabes JG, Turner RM 2nd, Fam MM, et al
    Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis.
    Urology. 2018 Nov 10. pii: S0090-4295(18)31136.
    PubMed     Abstract available

    October 2018
  83. ABBOUD MA, Topham AK, Parker DC, Burks HR, et al
    Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    Urology. 2018 Oct 22. pii: S0090-4295(18)31103.
    PubMed     Abstract available

  84. CHECK DK, Aaronson DS, Nielsen ME, Lee VS, et al
    Perioperative Intravesical Chemotherapy for Patients with Non-Muscle Invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-Recommended Use.
    Urology. 2018 Oct 22. pii: S0090-4295(18)31102.
    PubMed     Abstract available

    September 2018
  85. BUCHSER D, Zapatero A, Rogado J, Talaya M, et al
    Urology. 2018 Sep 25. pii: S0090-4295(18)30966.
    PubMed     Abstract available

  86. KHANNA A, Yerram N, Zhu H, Kim S, et al
    "Utilization of BCG for Non-Muscle Invasive Bladder Cancer in an Era of BCG Supply Shortages".
    Urology. 2018 Sep 13. pii: S0090-4295(18)30951.
    PubMed     Abstract available

    August 2018
  87. HAN DS, Zhou W, Seigne JD, Lynch KE, et al
    Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.
    Urology. 2018 Aug 20. pii: S0090-4295(18)30835.
    PubMed     Abstract available

  88. LOTAN Y
    Editorial Comment.
    Urology. 2018;118:111-112.

  89. RAYN KN, Ritchie C, Folio LR, Stamatakis L, et al
    Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7".
    Urology. 2018;118:e3-e4.
    PubMed     Abstract available

    June 2018
  90. FONTENOT PA JR, Barnes BD, Parker WP, Wyre H, et al
    Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation.
    Urology. 2018;116:131-136.
    PubMed     Abstract available

  91. BROCKMAN JA, Vetter J, Peck V, Strope SA, et al
    Effect of a Radical Cystectomy Care Pathway on Postoperative Length of Stay and Outcomes.
    Urology. 2018;116:125-130.
    PubMed     Abstract available

    May 2018
  92. TAPIERO S, Helfand A, Kedar D, Yossepowitch O, et al
    Patient Compliance with Maintenance Intravesical Therapy for Non-Muscle Invasive Bladder Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30473.
    PubMed     Abstract available

  93. CHALFIN HJ, Kates M, van der Toom EE, Glavaris S, et al
    Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
    Urology. 2018;115:82-86.
    PubMed     Abstract available

  94. ABELLO A, Delto JC, Wagner AA, Das AK, et al
    An Unusual Presentation of Metastatic Urothelial Bladder Carcinoma With Rhabdoid Features Presenting as Obstructive Uropathy.
    Urology. 2018;115:33-35.

    April 2018
  95. MANO R, Goldberg H, Stabholz Y, Hazan D, et al
    Urinary Tract Infections after Urinary Diversion - Different Occurrence Patterns in Patients with Ileal Conduit and Orthotopic Neobladder.
    Urology. 2018 Apr 4. pii: S0090-4295(18)30299.
    PubMed     Abstract available

  96. ALMASSI N, Ponziano M, Goldman HB, Klein EA, et al
    Reducing Overutilization of Preoperative Medical Referrals Among Patients Undergoing Radical Cystectomy Using an Evidence-based Algorithm.
    Urology. 2018;114:71-76.
    PubMed     Abstract available

    March 2018
  97. SCHOMBURG JL, Krishna S, Cotter KJ, Soubra A, et al
    Preoperative Incidence of Deep Venous Thrombosis in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Urology. 2018 Mar 15. pii: S0090-4295(18)30202.
    PubMed     Abstract available

  98. WYNER LM
    Leo Szilard's Bladder Cancer: Survival in the Nuclear Era.
    Urology. 2018 Mar 12. pii: S0090-4295(18)30178.

  99. ISLAM MM, Saltzman AF, Carrasco A Jr, Higuchi T, et al
    Incidental Discovery of Adenocarcinoma of an Augmented Bladder in a Patient With Myelomenigocele Undergoing Cystolithotomy.
    Urology. 2018;113:203-205.
    PubMed     Abstract available

  100. BARLOTTA R, Edwards DC, McGreen B, Levy J, et al
    Incidental Asymptomatic Leiomyoma of the Urinary Bladder.
    Urology. 2018;113:6-9.

    January 2018
  101. XIA L, Taylor BL, Mamtani R, Christodouleas JP, et al
    Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31331.
    PubMed     Abstract available

  102. ROBINS D, Matulay J, Lipsky M, Meyer A, et al
    Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy.
    Urology. 2018;111:116-121.
    PubMed     Abstract available

  103. DIMOPOULOS P, Kampantais S, Payne S, Liyanage S, et al
    Pseudomyxoma Peritonei Arising From Urachal Mucinous Adenocarcinoma.
    Urology. 2018;111:e3-e4.
    PubMed     Abstract available

    November 2017
  104. XU H, Ma J, Chen Z, Yang J, et al
    Safety and Efficacy of en Bloc Transurethral Resection with 1.9Mum Vela Laser for Treatment of Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 30. pii: S0090-4295(17)31231.
    PubMed     Abstract available

  105. SHINDO T, Shimizu T, Nojima M, Niinuma T, et al
    Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: a Two-Center Prospective Study.
    Urology. 2017 Nov 28. pii: S0090-4295(17)31223.
    PubMed     Abstract available

  106. MORA VIDAL R, Regufe da Mota S, Hayden A, Markham H, et al
    EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer.
    Urology. 2017 Nov 15. pii: S0090-4295(17)31184.
    PubMed     Abstract available

  107. GARRIDO-ABAD P, Diaz-Menendez A, Fernandez-Arjona M
    Bladder Herpes Infection in a Patient with Low-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 13. pii: S0090-4295(17)31175.
    PubMed     Abstract available

    September 2017
  108. SCHROECK FR, Patterson OV, Alba PR, Pattison EA, et al
    Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research.
    Urology. 2017 Sep 12. pii: S0090-4295(17)30966.
    PubMed     Abstract available

    August 2017
  109. WILLIAMS SB, Huo J, Chu Y, Baillargeon JG, et al
    Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making.
    Urology. 2017 Aug 25. pii: S0090-4295(17)30886.
    PubMed     Abstract available

  110. MARIAPPAN P, Lavin V, Phua CQ, Khan SAA, et al
    Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers - a Prospective Double-Blind Clinical Study.
    Urology. 2017 Aug 14. pii: S0090-4295(17)30802.
    PubMed     Abstract available

    July 2017
  111. KOO K, Zubkoff L, Sirovich BE, Goodney PP, et al
    The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.
    Urology. 2017 Jul 21. pii: S0090-4295(17)30754.
    PubMed     Abstract available

  112. MONCRIEF TJ, Balaji P, Lindgren B, Weight CJ, et al
    Comparative Evaluation of Bladder Specific Health Related Quality of Life (HRQOL) Instruments for Bladder Cancer.
    Urology. 2017 Jul 10. pii: S0090-4295(17)30698.
    PubMed     Abstract available

    May 2017
  113. DUNPHY KM, Garino MC, Shaw NM, Carvalho FL, et al
    When the Gold Standard Proves to be Fool's Gold - Blue Light Cystoscopy in a Case of High Risk Non-Muscle Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30581.

  114. SIHRA N, Diasuke N, Thurairaja R, Khan MS, et al
    Renal Tuberculosis Following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 May 31. pii: S0090-4295(17)30587.
    PubMed     Abstract available

  115. SORIA F, Moschini M, Wirth GJ, Gust KM, et al
    Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    Urology. 2017 May 12. pii: S0090-4295(17)30487.
    PubMed     Abstract available

    April 2017
  116. LAVOIE JM, Bidnur S, Black PC, Eigl BJ, et al
    Expanding Immunotherapy Options for Bladder Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30344.

    March 2017
  117. TONG C, Daskalakis N, Edwards DC, Cahn DB, et al
    Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder.
    Urology. 2017 Mar 31. pii: S0090-4295(17)30302.

  118. KLAASSEN Z, Soloway MS
    EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors.
    Urology. 2017 Mar 30. pii: S0090-4295(17)30297.

  119. ASHRAFI-ASGARABAD A, Ayubi E, Sullman MJ, Safiri S, et al
    Re: Hussein et al.: Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-Year Analysis (Urology 2016;97:124-129).
    Urology. 2017;101:174.

    February 2017
  120. PAK JS, Lee JJ, Bilal K, Finkelstein M, et al
    Utilization Trends and Short-Term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer.
    Urology. 2017 Feb 8. pii: S0090-4295(17)30124.
    PubMed     Abstract available

  121. ROBINS DJ, Sui W, Matulay JT, Ghandour R, et al
    Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30046.
    PubMed     Abstract available

  122. GOROSPE L, Garcia-Santana E, Jane-Soler P, Gomez-Martinez MDV, et al
    Cardiac and Skeletal Muscle Metastases From Squamous Cell Carcinoma of the Bladder: Positron Emission Tomography-Computed Tomography Findings.
    Urology. 2017;100:e5-e6.
    PubMed     Abstract available

  123. RUBENWOLF PC, Hampel C, Roos F, Stein R, et al
    Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience.
    Urology. 2017;100:249-254.
    PubMed     Abstract available

  124. BREAM MJ, Maurice MJ, Altschuler J, Zhu H, et al
    Increased Use of Cystectomy in Patients 75 and Older: A Contemporary Analysis of Survival and Perioperative Outcomes From the National Cancer Database.
    Urology. 2017;100:72-78.
    PubMed     Abstract available

  125. GOLABESK T, Palou J, Rodriguez O, Parada R, et al
    Long-term Bladder and Upper Urinary Tract Follow-up Recurrence and Progression Rates of G1-2 Non-muscle-invasive Urothelial Carcinoma of the Bladder.
    Urology. 2017;100:145-150.
    PubMed     Abstract available

    January 2017
  126. CHAPPIDI MR, Kates M, Brant A, Baras AS, et al
    Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    Urology. 2017 Jan 16. pii: S0090-4295(17)30031.
    PubMed     Abstract available

    December 2016
  127. SHINTANI T, Kusuhara Y, Daizumoto K, Dondoo TO, et al
    The Involvement of HGF-MET-MMP1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
    Urology. 2016 Dec 21. pii: S0090-4295(16)30945.
    PubMed     Abstract available

    September 2016
  128. SHIVAPPA N, Hebert JR, Rosato V, Rossi M, et al
    Dietary Inflammatory Index and Risk of Bladder Cancer in a Large Italian Case-Control Study.
    Urology. 2016 Sep 29. pii: S0090-4295(16)30637.
    PubMed     Abstract available

    April 2016
  129. PARKER WP, Toussi A, Tollefson MK, Frank I, et al
    Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy.
    Urology. 2016 Apr 25. pii: S0090-4295(16)30114.
    PubMed     Abstract available

    March 2016
  130. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.